Kiniksa Pharmaceuticals International, plc
KNSA
$27.65
-$0.09-0.32%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.95M | -43.19M | -9.07M | -10.23M | 8.65M |
| Total Depreciation and Amortization | 1.57M | 1.70M | 1.84M | 2.04M | 2.21M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 41.57M | 42.38M | 18.17M | 32.94M | 1.03M |
| Change in Net Operating Assets | 17.83M | 24.81M | 311.00K | 5.72M | 9.67M |
| Cash from Operations | 44.03M | 25.69M | 11.24M | 30.47M | 21.56M |
| Capital Expenditure | -292.00K | -277.00K | -140.00K | -156.00K | -190.00K |
| Sale of Property, Plant, and Equipment | 25.00K | 25.00K | 25.00K | 25.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -39.13M | 37.92M | -42.40M | -48.31M | 34.08M |
| Cash from Investing | -39.39M | 37.67M | -42.52M | -48.44M | 33.89M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 16.44M | 17.25M | 15.49M | 7.74M | 7.19M |
| Repurchase of Common Stock | -5.02M | -4.98M | -4.67M | -3.06M | -2.17M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 11.42M | 12.27M | 10.82M | 4.68M | 5.02M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 16.05M | 75.63M | -20.45M | -13.30M | 60.46M |